Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123138793 | 12313879 | 3 | F | 20160319 | 20160808 | 20160428 | 20160818 | EXP | US-BAYER-2016-060360 | BAYER | 78.00 | YR | E | F | Y | 90.70000 | KG | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123138793 | 12313879 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 123138793 | 12313879 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID | BXGZ9S2 | 204819 | 1 | MG | TID | ||||||
| 123138793 | 12313879 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID | BXH7U61 | 204819 | 1 | MG | TID | ||||||
| 123138793 | 12313879 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 0.5 MG, TID | 204819 | .5 | MG | TID | |||||||
| 123138793 | 12313879 | 5 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 0.5 MG, TID | BXHB1T1 | 204819 | .5 | MG | TID | ||||||
| 123138793 | 12313879 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 123138793 | 12313879 | 7 | C | LETAIRIS | AMBRISENTAN | 1 | 0 | ||||||||||||
| 123138793 | 12313879 | 8 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123138793 | 12313879 | 1 | Pulmonary arterial hypertension |
| 123138793 | 12313879 | 2 | Pulmonary arterial hypertension |
| 123138793 | 12313879 | 3 | Pulmonary arterial hypertension |
| 123138793 | 12313879 | 4 | Pulmonary arterial hypertension |
| 123138793 | 12313879 | 5 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123138793 | 12313879 | HO |
| 123138793 | 12313879 | OT |
| 123138793 | 12313879 | DE |
| 123138793 | 12313879 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123138793 | 12313879 | Back pain | |
| 123138793 | 12313879 | Blood pressure abnormal | |
| 123138793 | 12313879 | Chronic obstructive pulmonary disease | |
| 123138793 | 12313879 | Death | |
| 123138793 | 12313879 | Drug intolerance | |
| 123138793 | 12313879 | Gastrointestinal haemorrhage | |
| 123138793 | 12313879 | General physical health deterioration | |
| 123138793 | 12313879 | Hospitalisation | |
| 123138793 | 12313879 | Pathological fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123138793 | 12313879 | 1 | 20151012 | 0 | ||
| 123138793 | 12313879 | 8 | 2016 | 0 |